Iran’s nuclear chief said the country is seeking to export high-tech products including radiopharmaceuticals to other countries.
Speaking to reporters on the sidelines of the 29th Iranian Nuclear Conference on Sunday, Head of the Atomic Energy Organization of Iran Mohammad Eslami said that local nuclear scientists have crowned impressive achievements during the current Iranian year, which will end on March 20, according to Tasnim News Agency.
He said Iran has managed to develop a blood clotting powder used for controlling hemorrhage in major surgeries, noting that the country was deprived of such medicine due to foreign sanctions.
Iran’s Food and Drug Administration has approved the powder, which can be exported to other countries, Eslami added.
He also praised nuclear scientists for inventing a new method for the treatment of garbage leachate with plasma technologies.
Highlighting efforts to provide greater opportunities for research in nuclear technologies, Eslami said Iranian radiopharmaceuticals and nuclear medicine equipment are now being exported to other countries.
Earlier in December 2022, Eslami had said Iran aimed to become a global hub for manufacturing deuterium drugs.
“In a not-too-distant future, we will turn into a hub for manufacturing drugs based on deuterium, which are good alternatives to chemical drugs and have lower side effects in comparison (to those drugs),” he stated.